Quetiapine recalls
Quetiapine products have been recalled 5 times, most recently on 18 Mar 2020. The recalling company is usually The Harvard Drug Group. The most common reason is packaging defects.
Total recalls5since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 18 Mar 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 20%Class III 4 80%
Why quetiapine is recalled
Companies
By year
All quetiapine recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Quetiapine Fumarate Extended-Release Tablets, 50 mg per unit dose recalledQuetiapine | The Harvard Drug Group | Packaging Defects | Nationwide |
| Drug | CLASS III | Quetiapine Fumarate Extended-Release Tablets, 200 mg per unit dose recalledQuetiapine | The Harvard Drug Group | Packaging Defects | Nationwide |
| Drug | CLASS III | Quetiapine Fumarate Extended-Release Tablets, 300 mg per unit dose recalledQuetiapine | The Harvard Drug Group | Packaging Defects | Nationwide |
| Drug | CLASS III | Quetiapine Fumarate Extended-Release Tablets, 150 mg per unit dose recalledQuetiapine | The Harvard Drug Group | Packaging Defects | Nationwide |
| Drug | CLASS II | Quetiapine Tablets USP 400 mg recalled by Ascend LaboratoriesQuetiapine | Ascend Laboratories | Foreign Material | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.